The Role of Lachnospiraceae in Liver Diseases: Recent Advances and Clinical Application Prospects
International Journal of Molecular Sciences · 11.08.2026 · 27 (16) · 7175
DOI: 10.3390/ijms27167175 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.08.2026. Verfasst von Jincheng Feng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Hauptthemen laut MEDLINE: Liver Diseases, Gastrointestinal Microbiome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Wuhan Union Hospital, Hubei Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Chronic liver diseases impose a considerable global public health burden, yet available treatment options remain largely inadequate. The gut microbiota exerts a key modulatory effect on liver disease pathogenesis via the gut-liver axis. Among them, Lachnospiraceae, a dominant bacterial family in the healthy adult gut, has drawn growing interest in recent years. Lachnospiraceae exert protective functions by producing short-chain fatty acids, participating in secondary bile acid conversion, and synthesizing active metabolites such as N-acetyl-glutamic acid, thereby maintaining intestinal barrier integrity and regulating host metabolic and immune homeostasis. Extensive evidence indicates that in cirrhosis, alcohol-associated liver disease, and metabolic dysfunction-associated steatotic liver disease, Lachnospiraceae abundance is consistently and significantly reduced, and this decrease is closely correlated with disease severity and adverse prognosis. In hepatocellular carcinoma, however, different members of Lachnospiraceae exhibit functional divergence, with some butyrate-producing genera decreasing while other subgroups may become enriched and influence the tumor immune microenvironment. Live biotherapeutic products based on Lachnospiraceae have achieved clinical breakthroughs in recurrent Clostridioides difficile infection and metabolic syndrome, providing important references for their translational application in liver diseases. This review systematically synthesizes the abundance changes and mechanisms of Lachnospiraceae across major liver diseases, evaluates their biomarker and therapeutic target potential, and seeks to provide fresh perspectives for precision microbiome-modulating strategies in chronic liver disease management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Förderung
- National Natural Science Foundation of China
- Wuhan Union Hospital
- Hubei Provincial Natural Science Foundation of China
Zitieren
APA
Feng, J., Wang, X., Cao, H., Zhang, Y., Xu, J., Wang, G., Zhu, X., & Deng, S. (2026). The Role of Lachnospiraceae in Liver Diseases: Recent Advances and Clinical Application Prospects. International Journal of Molecular Sciences, 27(16), 7175. https://doi.org/10.3390/ijms27167175
Vancouver
Feng J, Wang X, Cao H, Zhang Y, Xu J, Wang G, et al. The Role of Lachnospiraceae in Liver Diseases: Recent Advances and Clinical Application Prospects. International Journal of Molecular Sciences. 2026;27(16):7175. doi:10.3390/ijms27167175
BibTeX
@article{Feng2026,
author = {Feng, Jincheng and Wang, Xueling and Cao, Huan and Zhang, Yu and Xu, Jianjun and Wang, Guoliang and Zhu, Xiaodan and Deng, Shenghe},
title = {The Role of Lachnospiraceae in Liver Diseases: Recent Advances and Clinical Application Prospects},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {16},
pages = {7175},
doi = {10.3390/ijms27167175}
}
EUVIMED